EFCAB10: A Drug Target / Disease Biomarker (G100130771)

Target Name: EFCAB10

NCBI ID: G100130771

EFCAB10

EFCAB10: A Drug Target / Disease Biomarker

EFCAB10 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the EFCAB gene family, which is characterized by the presence of a unique juxtamicrosomere region (JMR) in the cytoplasm of the cell. The JMR is a region that is rich in protein diversity and has been implicated in various cellular processes, including the regulation of mitochondrial function and the development of neurodegenerative diseases.

One of the unique features of EFCAB10 is its ability to interact with other proteins in the cell. It has been shown to form complex with a variety of proteins, including the transcription factor NF-kappa-B and the protein known as p16INK4a. These interactions are important for the function of EFCAB10 and play a role in the regulation of various cellular processes, including cell growth, differentiation, and inflammation.

In addition to its role in cellular signaling, EFCAB10 has also been shown to be involved in the regulation of cellular processes that are important for the development and progression of neurodegenerative diseases. For example, studies have shown that EFCAB10 is involved in the regulation of neuroinflammation, which is the hallmark of many neurodegenerative diseases, including Alzheimer's and Parkinson's diseases.

The potential drug targets for EFCAB10 are vast and varied. One of the most promising targets is the potential inhibitor of EFCAB10, which has been shown to have therapeutic benefits in various neurodegenerative diseases. Studies have shown that inhibiting EFCAB10 can reduce neuroinflammation and improve the cognitive function in a variety of neurodegenerative models, including mouse models of Alzheimer's and Parkinson's diseases.

Another potential drug target for EFCAB10 is its role in the regulation of mitochondrial function. Mitochondria are important organelles that are involved in the regulation of cellular processes that are critical for energy metabolism and the development of neurodegenerative diseases. EFCAB10 has been shown to be involved in the regulation of mitochondrial function and has been implicated in the development of certain neurodegenerative diseases.

In conclusion, EFCAB10 is a protein that is involved in various cellular processes that are important for the development and progression of neurodegenerative diseases. Its unique juxtamicrosomere region and ability to interact with other proteins make it an attractive target for the development of new therapies for a variety of neurodegenerative diseases. Further research is needed to fully understand the role of EFCAB10 in neurodegenerative diseases and to develop effective treatments.

Protein Name: EF-hand Calcium Binding Domain 10

The "EFCAB10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EFCAB10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets